Ramsay stock gains as FY26 revenue rises and EBIT margin improves

Ramsay stock is trading firmer after the healthcare group reported higher FY26 revenue, improved margins and a larger dividend, while investors weigh a planned separation of its European business Ramsay Sante.

Ramsay stock is trading around 52.29 Australian dollars as of September 4, 2026, with the private hospital operator (ISIN AU000000RHC8) supported by improving profitability and rising dividends reported for fiscal year 2026.

FY26 results show revenue and margin progress

According to an overview of top Australian healthcare shares published by Motley Fool on September 4, 2026, Ramsay Health Care reported fiscal year 2026 revenue of 18.6 billion Australian dollars, confirming that the group continues to generate substantial scale across its hospital network.

The same analysis notes that underlying EBIT reached 1.2 billion Australian dollars in FY26, representing an 11.8 percent increase compared with the previous fiscal year, which signals that Ramsay is converting more of its revenue into operating profit despite cost pressures in healthcare.

Motley Fool also highlights that Ramsay's EBIT margin improved by 30 basis points to 6.2 percent in fiscal year 2026, a change that, while modest in absolute terms, is closely watched by investors because small shifts in margin can significantly influence returns in a capital-intensive hospital business.

For income-focused shareholders, the article points out that Ramsay lifted its full-year dividend by 13.8 percent to 0.91 Australian dollars per share in FY26, underlining management's confidence in cash generation and offering a tangible reward for holding the stock.

Strategic separation of Ramsay Sante and investor implications

The same Motley Fool piece reports that Ramsay plans to separate Ramsay Sante, its European healthcare business, with a shareholder vote scheduled for November 24, 2026, creating a potential structural catalyst that could reshape the group’s geographic exposure.

For investors, the proposed separation of Ramsay Sante raises concrete questions about how earnings, growth prospects and capital allocation will be divided between the core Australian operations and the European assets once the transaction is completed, especially given the scale of Ramsay's FY26 revenue base.

With underlying EBIT up 11.8 percent and the dividend growing more than ten percent in fiscal year 2026, some market participants may view the planned Ramsay Sante transaction as an opportunity to unlock value from a business that contributed to that 18.6 billion Australian dollars revenue figure, while others will focus on execution risks around the restructuring.

The combination of higher EBIT, a wider margin and a larger dividend in FY26 suggests that Ramsay is entering the separation process from a position of relative financial strength, which can be important when engaging shareholders ahead of the November 24, 2026 vote.

Representative Ramsay Health Care service

Ramsay operates a broad portfolio of private hospitals and day surgery centers, and Ramsay Health Care UK illustrates the group’s international reach by providing elective surgeries, diagnostics and specialist treatments to patients in England within a framework that complements public healthcare provision.

Ramsay stock price snapshot and market data

Market data compiled by Yahoo Finance via a Cochlear Limited quote page shows that Ramsay Health Care's RHC.AX listing was quoted at approximately 52.29 Australian dollars with a daily gain of about 0.95 percent as of September 4, 2026, placing the share price comfortably within its recent trading range on the Australian Securities Exchange.

Ramsay stock key data

• Company: Ramsay Health Care Limited
• ISIN: AU000000RHC8
• Ticker: RHC
• Trading venue: ASX
• Price (as of September 4, 2026): 52.29 AUD
• Sector / Industry: Healthcare - Hospitals
• Index membership: S&P/ASX 200